Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Neurosurgery|February 14, 2007
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioningJohn H Sampson, Martin L Brady, Neil A Petry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 11, 2025
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety riskTiffany Kim, Allen Brinker, David Croteau, et al.
AIDS (London, England)|February 9, 2012
Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentrationDavid Croteau, Brookie M Best, Scott Letendre, et al.
Journal of Neurosurgery|July 21, 2007
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical noteRussell R Lonser, Katherine E Warren, John A Butman, et al.
Neurosurgery|December 20, 2007
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety resultsMichael A Vogelbaum, John H Sampson, Sandeep Kunwar, et al.
Neuro-Oncology|June 1, 2010
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastomaSandeep Kunwar, Susan Chang, Manfred Westphal, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Pageof 4